5 completed. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow Hypercalcemia: new trials by email Literature Review of Hypercalcemia trials Research Report on Hypercalcemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma Tivantinib, Diagnostic laboratory biomarker analysis, Questionnaire administration - Refractory Multiple Myeloma | Phase 2 | Completed | National Cancer Institute (NCI) | 16 | 2011-11-01 | 2019-08-28 |
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium denosumab - Breast Cancer, Hypercalcemia of Malignancy | Phase 2 | Completed | Amgen | 33 | 2009-11-16 | 2018-10-17 |
| Effect of Vitamin D Treatment in Primary Hyperparathyroidism Cholecalciferol - Vitamin D Deficiency, Primary Hyperparathyroidism | Phase 2 / Phase 3 | Completed | University of Aarhus | 46 | 2008-05-01 | 2013-11-18 |
| Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients. physiological (1.25 mmol/L ) calcium dialysate - Hyperparathyroidism, Hypercalcemia | Phase 2 | Completed | Sun Yat-sen University | 180 | 2006-04-01 | 2015-05-22 |
| Studies of Elevated Parathyroid Activity 68Ga-Dotatate, 18F-DOPA - Hyperparathyroidism, Hypercalcemia | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1553 | 1993-12-15 | 2022-06-07 |
Hyperparathyroidism (2) · Multiple Myeloma (2) · Parathyroid Neoplasms (2) · Amyloidosis (1) · Anemia (1) · Bone Diseases, Metabolic (1) · Breast Neoplasms (1) · Calcinosis (1) · Carcinoma, Non-Small-Cell Lung (1) · Cardiovascular Diseases (1) · Colonic Neoplasms (1) · Endocrine Gland Neoplasms (1) · Fractures, Spontaneous (1) · Head and Neck Neoplasms (1)
Calcium Metabolism Disorders (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Water-Electrolyte Imbalance (5) · Endocrine System Diseases (4) · Parathyroid Diseases (4) · Neoplasms by Site (3) · Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2)
ARQ 197 (1) · Cholecalciferol (1) · Denosumab (1) · Vitamin D (1) · fluorodopa F 18 (1) · gallium Ga 68 dotatate (1)
Amgen (1) · National Cancer Institute (NCI) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Sun Yat-sen University (1) · University of Aarhus (1)
United States (3) · Canada (1) · China (1) · Denmark (1) · France (1) · Italy (1) · Poland (1)
Haitang Hu, MD (1) · Lars Rejnmark, MD,PhD,DrMed (1) · Lars Rolighed, MD (1) · Qiong Luo, MD (1) · Robert Orlowski (1) · Smita Jha, M.D. (1) · Tanqi Luo, MD (1) · Wei Shi, MD (1) · Xueqing Yu, MD (1) · Yaozhong Kong, MD (1) · Zaiseng Zhou, MD (1)
N01CM00039 (1), P30CA016672 (1), U01CA062461 (1)